From ‘Sex-Change Surgery’ to G05 ‘Gender Reassignment Technology’: A Comparative Guide to China’s 2009, 2017, and 2022 National Medical Rules

Abstract

Mainland China’s national regulation of transgender-related surgery can be compared through three directly connected rule sets. In 2009, the Ministry of Health issued the trial Technical Management Standard for Sex-Change Surgery, treating “sex-change surgery” as the regulated medical technology. In 2017, a new national package for medical technologies with restricted clinical application used the term “gender reassignment technology” and replaced the 2009 standard. In 2022, the National Health Commission retained gender reassignment technology as national restricted technology G05 and issued a revised clinical-application standard. Across all three versions, hospital capacity, surgeon experience, applicant eligibility, informed consent, ethics review, medical records, and follow-up form a linked regulatory system, while the architecture of those links changes over time (Ministry of Health 2009; National Health and Family Planning Commission 2017; National Health Commission 2022).

This article builds a regulatory crosswalk with fields for regulatory_object, institution_gate, clinician_gate, candidate_documents, candidate_eligibility, core_procedure, certificate_trigger, ethics_process, reporting, training, and quality_control. The comparison reveals two simultaneous trajectories. The first is the candidate-access gate. By 2022, the age threshold had moved from above twenty to eighteen, the written request shifted from notarization to the applicant’s own signature, the diagnostic wording explicitly accommodated “gender dysphoria” and “gender incongruence,” and the separate one-year unsuccessful psychological or psychiatric treatment condition present in both the 2009 and 2017 rules disappeared from the principal eligibility list. The second is the institutional-governance gate. Multidisciplinary discussion, case databases, provincial information reporting, training systems, and quality-control mechanisms became increasingly explicit (PROJECT TRANS 2017, 2022; National Health Commission Medical Administration Bureau 2022).

The history is therefore best read as a reorganization of medical-technology governance. National rules simultaneously manage access to a major surgical pathway, institutional safety, clinician competence, technical quality, and an administrative interface for later legal procedures. A changed clause gains historical meaning when it is placed back into that complete matrix: which gate changed, whose action changed, what evidence became required, and which downstream process the clause connected to.

Keywords: transgender; mainland China; medical history; gender reassignment technology; gender reassignment surgery; medical technology regulation; G05; health policy; policy comparison

1. Research question: why was the same field of surgery nationally re-encoded three times?

The public institutional history of transgender-related surgery in mainland China contains several parallel histories: clinical practice, psychiatric classification, hospital organization, legal gender recognition, and medical-technology regulation. GenderLibs has separately examined early surgical records, the public archive of Peking University Third Hospital, diagnostic classification, and claims about medical “firsts.” This article isolates a different institutional line: how national health authorities defined this surgery as a regulated medical technology in 2009, 2017, and 2022, and how each version specified who could perform it, where it could be performed, who could enter the pathway, which documents had to be collected, and when a hospital could issue a certificate for later legal procedures.

The three dates are textually connected. The 2009 standard belonged to the medical-technology clinical-application management system of its period. The 2017 National Health and Family Planning Commission package introduced fifteen standards for medical technologies with restricted clinical application, placed “gender reassignment technology” within that framework, and expressly superseded the 2009 standard. The 2018 Measures for the Administration of Clinical Application of Medical Technologies then established a broader structure centered on a negative list, medical quality and safety, and institutional responsibility. When the National Health Commission revised the national restricted-technology list in 2022, gender reassignment technology remained on it under the code G05 (National Health and Family Planning Commission 2017; National Health Commission 2018a, 2018b; National Health Commission Medical Administration Bureau 2022).

Terminology offers an initial clue. The 2009 expression translated here as “sex-change surgery” foregrounded a surgical event. The 2017 expression “gender reassignment technology” embedded the practice in the vocabulary of medical-technology governance. G05 in 2022 added a formal catalogue code inside the national restricted-technology system. More consequential changes appeared underneath the names: hospital bed requirements shifted; the eligible professional background of principal surgeons changed; the minimum age fell; diagnostic language broadened; notarization disappeared; an explicit one-year preoperative psychological or psychiatric treatment condition disappeared; the set of procedures to which the applicant prerequisites applied narrowed; the point at which a hospital could issue a certificate changed; and multidisciplinary review and information reporting became more explicit.

The central question is therefore: how did the three national standards organize the candidate-access gate and the institutional-governance gate, which requirements persisted, which were revised, and which new quality-control mechanisms entered the rules? News coverage frequently compresses the 2022 change into a single headline such as “minimum age lowered to 18” or “notarization no longer required.” A clause-level crosswalk preserves the surrounding rules, allowing a reader to identify whether a change concerns age, diagnosis, family notification, marital status, hospital qualifications, clinician training, ethics, the scope of the core procedure, or the documentary bridge to later legal procedures.

2. Materials and method: placing three generations of rules into one regulatory crosswalk

2.1 Source hierarchy

The comparison gives highest priority to formal documents issued by national health authorities. The core 2009 source is the Ministry of Health notice publishing the trial technical standard. The 2017 source is the National Health and Family Planning Commission package of management standards and quality-control indicators for restricted technologies. The 2022 sources include the National Health Commission notice and its official policy explanation (Ministry of Health 2009; National Health and Family Planning Commission 2017; National Health Commission 2022; National Health Commission Medical Administration Bureau 2022).

Several attachments survive mainly as PDF files or on older government sites. For clause-level searching, this article also uses public textual mirrors maintained by PROJECT TRANS, Peking University Third Hospital, and TGR. These mirrors improve accessibility and preservation. Regulatory authority remains anchored in the issuing national authority and the version of the rule.

Contemporaneous journalism has a different evidentiary function. Reports on the June 2009 consultation draft described proposed requirements involving a period of public life or work in the target gender and police documentation concerning later identity-card changes. When the final standard appeared in November, journalists compared draft and final provisions and recorded that several proposed conditions remained at the consultation stage (Legal Evening News 2009a, 2009b; Beijing Times 2009). The draft-to-final history demonstrates why a policy archive needs explicit version status. A requirement reported during consultation belongs to the history of policy formation, while the final text establishes the enacted rule.

Academic and research sources answer a third class of questions. National transgender surveys, studies of health-care demand, mental-health research, legal-gender-recognition reviews, international clinical guidelines, and ICD-11 scholarship help locate regulatory clauses within clinical and social experience (Liu et al. 2020; Chen et al. 2019; Dahlkemper et al. 2019; UNDP 2018). Those studies describe populations, services, health outcomes, and professional frameworks. The national standards describe the regulatory conditions attached to a particular class of surgery at a particular time.

2.2 Eleven comparison fields

The regulatory crosswalk uses eleven fields:

1. regulatory_object: what the rule defines as the regulated medical technology;
2. institution_gate: hospital departments, beds, equipment, ethics bodies, and other institutional prerequisites;
3. clinician_gate: professional specialty, rank, years of practice, prior cases, and training requirements for surgeons;
4. candidate_documents: certificates, diagnoses, applications, and family-notification materials collected from an applicant;
5. candidate_eligibility: age, marital status, civil capacity, persistence of surgical request, and other qualification criteria;
6. core_procedure: which bodily interventions belong to the core technology and trigger the applicant prerequisites;
7. certificate_trigger: the surgical stage at which a medical certificate for subsequent legal procedures may be issued;
8. ethics_process: informed consent, ethics approval, and multidisciplinary deliberation;
9. reporting: case registration, databases, information platforms, and administrative reporting;
10. training: clinician training and requirements for training bases;
11. quality_control: pathology, follow-up, competency reassessment, device traceability, and other safety mechanisms.

These fields separate applicant requirements from hospital requirements and separate the performance of surgery from the issuance of a later administrative document. The comparison also records publication_time, effective_context, superseded_by, and source_version. Each historical claim can therefore be traced to a concrete version and a concrete clause dimension.

2.3 The two-gate model

The article summarizes the matrix through a candidate-access gate and an institutional-governance gate. The first determines what an applicant must satisfy before entering the core surgical pathway. The second determines which institution and clinician may perform the technology and under what ethics, training, reporting, and quality-control arrangements. The two gates can move in different directions. Several applicant-facing conditions became narrower or simpler in 2022 while institutional data, deliberation, and quality governance became more structured. Keeping the two gates distinct preserves that simultaneous movement.

3. 2009: writing “sex-change surgery” into a national medical-technology access system

The institutional position of the 2009 standard is unusually clear. It was the first dedicated national technical-management standard to systematically specify institution, clinician, applicant, and technical-management requirements for “sex-change surgery.” The formal notice was issued in November and used the surgical term as its regulated object (Ministry of Health 2009).

The institutional gate was demanding. Contemporaneous reporting and the standard describe requirements concerning plastic-surgery capacity, ethics review, equipment, and emergency capability. Principal surgeons needed extensive plastic-surgery experience, senior professional qualifications, and prior experience with relevant procedures (Yangcheng Evening News 2009; Beijing Morning Post 2009). These clauses embody a regulatory logic that persists across later versions: gender-related genital surgery was treated as a relatively infrequent and high-risk technology that should be concentrated in institutions and teams with demonstrable capability.

The applicant side combined multiple forms of evidence. The final rule required proof of no criminal record, a psychiatric diagnosis using the terminology of the period, the applicant’s written request with notarization, and proof that immediate family members had been informed. It also required the desire for surgical transition to have remained stable for at least five years, at least one year of unsuccessful psychological or psychiatric treatment, unmarried status, an age above twenty, and full civil capacity (Ministry of Health 2009; Yangcheng Evening News 2009). Headlines often emphasized “unmarried” and “above 20,” yet the complete access gate also connected diagnosis, long-term intention, family relations, criminal-record documentation, notarization, ethics, and surgical risk.

The 2009 text additionally contained diagnostic exclusions characteristic of that period, including restrictions concerning comorbid mental illness and a separately worded exclusion involving homosexuality in the older rule’s clinical taxonomy. The 2017 version omitted those exclusionary clauses while retaining the main structure of diagnosis, five-year stable intention, one-year unsuccessful psychological or psychiatric treatment, marital status, age, notarized application, and family notification (PROJECT TRANS 2017). The comparison therefore captures change in the boundary of the diagnostic gate as well as change in the number of requirements.

The policy-making process in 2009 leaves a second historical layer: the consultation draft. June reporting described proposed provisions that would have required a period of living or working publicly in the target gender and documentation from public-security organs concerning post-operative identity information. In November, media comparisons placed several of those provisions in the consultation-stage record rather than the final standard (Legal Evening News 2009a, 2009b; Beijing Times 2009). A robust historical record therefore distinguishes at least two 2009 objects: the consultation proposal and the final technical standard. A June news report is evidence of policy formation and public debate; the November rule establishes the final national technical requirements.

The professional vocabulary also belongs to its period. National rules, medical teaching, and clinical practice frequently used older diagnostic expressions corresponding to “transsexualism” or local Chinese diagnostic terminology. During the following decade, WPATH standards, Endocrine Society guidelines, DSM-related scholarship, and the ICD-11 revision contributed to a broader professional vocabulary of transgender health and gender incongruence (Hembree et al. 2009; Coleman et al. 2012; Reed et al. 2019). The 2009 standard is therefore both a surgical-access document and an institutional snapshot of how diagnosis, family, administrative evidence, and medical risk were connected at the time.

4. 2017: moving from a trial surgery standard into the system of restricted clinical technologies

The first major change in 2017 occurred in regulatory architecture. The National Health and Family Planning Commission issued management standards and quality-control indicators for fifteen medical technologies with restricted clinical application. “Gender reassignment technology” was one of them, and the new package expressly abolished the 2009 trial standard (National Health and Family Planning Commission 2017; CN-Healthcare 2017). The phrase “restricted clinical application” is important. The technology remained clinically available, while institution, personnel, training, case management, and quality control were organized within a standardized national restriction framework.

The 2017 standard defined gender reassignment technology through surgical alteration of sex-related bodily characteristics and specified detailed institutional qualifications. The searchable text requires appropriate clinical departments and an ethics committee, an established plastic-surgery service, a defined bed capacity and annual surgical volume, at least two registered physicians capable of performing the technology, and microsurgical equipment. The plastic-surgery bed threshold was thirty (PROJECT TRANS 2017).

Clinician qualification became more explicitly institutionalized. Principal surgeons needed long-term plastic-surgery experience, a senior professional title, and prior experience in genital reconstruction. The rule also specified provincial training, training duration, case participation, and training-base requirements. The regulatory question therefore expanded from whether a surgeon already had experience to how the restricted-technology system could train and assess future qualified clinicians (PROJECT TRANS 2017; Peking University Third Hospital Plastic Surgery Department 2022).

Applicant eligibility shows substantial continuity with 2009. The searchable 2017 text continued to require evidence of no criminal record, a psychiatric or psychological professional diagnosis, a written and notarized request, and documentation showing that immediate relatives had been informed. It retained a surgical request lasting at least five years, at least one year of unsuccessful psychological or psychiatric treatment, unmarried status, an age above twenty, and full civil capacity (Ministry of Health 2009; PROJECT TRANS 2017). At the same time, the 2017 text omitted several diagnostic exclusions found in the 2009 rule. Through the candidate-access lens, 2017 kept the central social and medical eligibility structure while redrawing part of the diagnostic boundary.

The scope of procedures to which those prerequisites applied also changed. The 2009 access conditions reached genital removal and reconstruction as well as procedures changing secondary sex characteristics. The 2017 rule defined the principal procedures more narrowly as removal and reconstruction of external genitalia plus mastectomy in female-to-male surgery (Ministry of Health 2009; PROJECT TRANS 2017). core_procedure therefore matters historically: regulatory change can occur through altered prerequisites and through a changed definition of which procedures activate those prerequisites.

The 2017 standard also created a significant documentary interface after surgery. It instructed medical institutions to issue a relevant medical certificate after external-genital reconstruction so that the patient could undertake subsequent legal procedures. Pathology, case registration, follow-up, privacy protection, and periodic assessment of institutional capability also appeared in the technical-management provisions (PROJECT TRANS 2017). The rule thus linked the medical pathway to legal gender recognition at a specific surgical point. UNDP’s 2018 policy review shows that medical documentation interacted with household registration, identity documents, education, employment, and other administrative systems, while actual implementation could still depend on multiple institutions and local practice (UNDP 2018). The hospital certificate was one key bridge within that wider system.

5. The 2018 institutional background: negative lists, institutional responsibility, and quality safety

The interval between the 2017 and 2022 technical standards contains another important national development. In 2018, the National Health Commission promulgated the Measures for the Administration of Clinical Application of Medical Technologies, effective on November 1 of that year. The measures organized medical-technology governance around quality and safety, institutional responsibility, classified management, and national and provincial lists of prohibited or restricted technologies (National Health Commission 2018a, 2018b).

This broader rule helps explain why the 2022 revision combines applicant-eligibility changes with information platforms, quality control, and institutional governance. Gender reassignment technology is a national restricted technology, so its specialized standard sits within a larger governance framework. The regulatory_object field therefore records both the technology itself and the regulatory category in which national authorities placed it.

The same context clarifies the recurring language of risk and competence. Medical-technology regulation is charged with protecting quality and patient safety; restricted technologies consequently attract requirements concerning institutional capability, clinician experience, case management, equipment, traceability, and follow-up. Transgender-health research, meanwhile, documents a different but overlapping risk landscape: limited access to specialized services, financial barriers, self-medication, uneven professional knowledge, and regional disparities (Dahlkemper et al. 2019; Liu et al. 2020; Yang et al. 2024; Cai et al. 2026; He et al. 2026). The national standard governs how an authorized major surgical technology is delivered. Population research shows how people reach, delay, or bypass formal services. Both are necessary for a complete medical history.

6. 2022: G05 rewrites several candidate-facing requirements while making institutional governance more explicit

In 2022, the National Health Commission updated the national restricted-technology catalogue and corresponding clinical-application standards. Gender reassignment technology remained in the national list as G05. The official policy explanation situated the revision within negative-list management, ongoing supervision, quality safety, and information-based reporting, with medical institutions responsible for reporting clinical application of restricted technologies through the appropriate information systems (National Health Commission Medical Administration Bureau 2022).

6.1 Age: from above twenty to eighteen

The 2022 standard requires a person seeking the principal gender-reassignment surgery to be at least eighteen years old. Both the 2009 and 2017 rules used an above-twenty threshold (Ministry of Health 2009; PROJECT TRANS 2017, 2022). Chinese community reporting and English-language coverage quickly identified the age change as one of the most visible features of the revision (Xintong 2022; The China Project 2022). In the crosswalk, this belongs to candidate_eligibility.age. Reading it together with the other eligibility fields preserves the complete access gate.

6.2 Diagnosis: one administrative clause accommodates multiple generations of terminology

The 2022 rule requires a diagnosis from the psychiatry or psychology department of a tertiary hospital and uses wording that places “gender dysphoria” and “gender incongruence” alongside the older Chinese clinical category (PROJECT TRANS 2022). Several generations of professional language are therefore made usable at the same administrative interface.

The World Health Organization’s ICD-11 moved gender incongruence to the chapter on conditions related to sexual health, and international professional guidelines have continued to revise the clinical framework for gender-affirming care (WHO 2022; Coleman et al. 2022). The Chinese surgical-technology standard presents a transitional administrative vocabulary in which older domestic clinical terminology and newer international terms can serve a documentary function.

This point complements GenderLibs’ separate history of diagnostic classification. That article asks how classification systems moved over time. The narrower question here is: when diagnosis functions as an application document for a nationally restricted surgery, which diagnostic labels does the technical standard recognize at that gate? A term can have different institutional functions in classification, ordinary clinical practice, and surgical access.

6.3 Written request: from notarization to the applicant’s own signature

Both the 2009 and 2017 standards required the applicant’s written request and notarization. The 2022 rule requires a written application signed by the applicant and omits notarization from the listed documents (Ministry of Health 2009; PROJECT TRANS 2017, 2022). This is a change in candidate_documents. It removes one layer of external certification while retaining a formal written record of the applicant’s expressed surgical request. Community reporting in 2022 likewise highlighted the disappearance of notarization as a practical change (Xintong 2022).

Family-related documentation remained. The 2022 text still calls for proof that immediate relatives have been informed. Unmarried status, proof of no criminal record, full civil capacity, and a stable request sustained for at least five years also continue (PROJECT TRANS 2022). The candidate-access gate was therefore reorganized: some requirements became simpler while several social-documentary conditions persisted.

6.4 The psychological or psychiatric treatment prerequisite: retained across two generations, then removed from the main eligibility list

The 2009 and 2017 texts both expressly required at least one year of unsuccessful psychological or psychiatric treatment. The 2022 version moves that independent requirement out of the principal eligibility list (Ministry of Health 2009; PROJECT TRANS 2017, 2022; The China Project 2022). Precise wording matters here. The 2022 version still requires a diagnosis from psychiatry or psychology. The change concerns the disappearance of the separate one-year unsuccessful-treatment requirement from the principal eligibility list.

This distinction is important for histories of depathologization. A diagnostic interface, a treatment prerequisite, and a person’s identity are different institutional layers. ICD-11 changed both placement and terminology and places trans-related identities outside the category of mental ill-health. China’s restricted-technology standard governs eligibility and safety for a specific surgery. The two systems meet linguistically in the 2022 text while retaining different institutional authority (WHO 2022; Reed et al. 2019).

6.5 Scope of the principal procedure: the set of surgeries activating the prerequisites narrows over time

The national standards also changed the scope of procedures to which the applicant prerequisites applied. The 2009 framework reached genital removal and reconstruction and surgery changing secondary sex characteristics. The 2017 standard defined principal surgery as removal and reconstruction of external genitalia plus mastectomy in female-to-male surgery. The 2022 main-object clause focuses on genital removal and reconstruction (Ministry of Health 2009; PROJECT TRANS 2017, 2022).

This is a core_procedure change. It shows that access can shift through the content of an eligibility requirement and through the boundary of procedures to which the requirement attaches. Transgender-related health care contains many surgical and nonsurgical services; G05 governs the subset defined by national authorities as this restricted core technology.

6.6 The certificate trigger: from completed external-genital reconstruction to removal of gonads and original external genitalia

The 2017 standard linked the medical certificate used for later legal procedures to completion of external-genital reconstruction. The 2022 standard permits the medical institution to issue the relevant certificate after removal of the gonads and original external genitalia (PROJECT TRANS 2017, 2022). This change sits outside the age-focused summary that dominated much contemporaneous coverage.

It relocates the interface between a surgical sequence and later administrative procedures. Under the 2022 wording, the certificate can be generated before complete external-genital reconstruction. certificate_trigger and core_procedure therefore occupy different points in the sequence. Legal gender recognition retains its own administrative rules and local implementation, so the medical certificate remains one component of a larger process (UNDP 2018). Historically, the change also demonstrates that “completion of surgery” can have distinct clinical, regulatory, and administrative meanings.

6.7 Multidisciplinary deliberation, case data, and provincial information platforms

The 2022 standard explicitly calls for hospital deliberation, ethics review, and multidisciplinary discussion for relevant cases. It requires institutions to establish case databases and to report restricted-technology application through the relevant provincial information platform (PROJECT TRANS 2022; National Health Commission Medical Administration Bureau 2022). These clauses are among the clearest additions to the institutional-governance gate.

The 2017 standard already contained case management, training, follow-up, and competency assessment. The 2022 text makes information reporting and multidisciplinary governance more concrete. Medical-technology regulation thus continues to expand from qualification toward the internal discussion, recording, reporting, monitoring, and follow-up of each case. This development aligns with the 2018 national measures emphasizing institutional responsibility, quality safety, and dynamic management of restricted technologies (National Health Commission 2018a).

7. Clause-by-clause crosswalk: what changed at which gate?

The following table compresses major clauses into one coordinate system. It describes the national rule texts. Local implementation and the actual workflow of individual hospitals require separate evidence.

The table is most useful because it locates simplification and strengthening in different columns. In 2022, age, notarization, the treatment prerequisite, procedure scope, and the certificate trigger show changes in several applicant-facing conditions or in the reach of those conditions. The same version also adds or strengthens multidisciplinary deliberation, information reporting, internal hospital decision-making, and quality governance. Policy history can therefore describe two simultaneous institutional trajectories as complementary parts of the same revision.

8. Continuity matters: marital status, criminal records, family notification, and long-term intention persist

Policy comparison naturally attracts attention to new language, yet persistent clauses reveal what the system continued to value. The 2022 standard retains unmarried status, evidence of no criminal record, proof that immediate relatives have been informed, a five-year stable request for surgery, and full civil capacity (PROJECT TRANS 2022). These provisions connect medical eligibility to family status, marriage, criminal-record administration, and a temporally documented identity narrative.

Transgender-health research shows that these domains are socially consequential. National surveys and later studies document interactions among family relations, social pressure, mental health, medical demand, and economic access (Chen et al. 2019; Liu et al. 2020; Wang et al. 2023). UNDP’s legal-gender-recognition review further shows how medical processes can accumulate with identity documents, education, employment, and other institutions in a person’s life (UNDP 2018). A family-notification or unmarried-status clause is therefore part of both medical-policy history and broader social-institutional history.

The five-year stable-request provision also reflects a particular theory of evidence: the regulatory system asks for temporal continuity that can be documented. Contemporary clinical guidelines place greater emphasis on individualized assessment, informed consent, shared decision-making, treatment goals, and risk-benefit analysis (Hembree et al. 2017; Coleman et al. 2022). Placing the two document families side by side shows that a national technology-access rule and an international clinical guideline operate with different units of governance. The first needs administrable eligibility and safety conditions; the second is oriented more closely to clinical decision-making for an individual patient.

9. “Gender reassignment technology” covers the core surgical-technology layer of transgender health care

All three national standards center a major surgical technology and therefore describe the core surgical-technology layer within a broader field of transgender health care. Chinese national population research shows substantial demand for both hormone therapy and surgery, while formal-service access, cost, professional resources, and regional inequality shape actual pathways (Liu et al. 2020). Recent studies further document antiandrogen use, self-medication, hormone-utilization milestones, and disparities by age, education, income, and region (Yang et al. 2024; Hou et al. 2026; Cai et al. 2026; He et al. 2026).

A G05 standard answers how the state regulates a class of high-risk surgery. The wider question of continuous, affordable, competent gender-affirming care in a given city requires evidence about clinic distribution, medication, insurance, community resources, income, discrimination, and travel between regions, alongside the technology catalogues, hospital qualifications, clinician qualifications, and case governance that answer the regulatory question (Dahlkemper et al. 2019; UNDP 2016).

This boundary explains the value of community sources in policy history. Community reporting on the 2022 rules rapidly focused on age, notarization, and psychological-treatment requirements because these clauses directly changed the application pathway. Professional studies then illuminate experiences outside the formal surgical route, including self-medication and delayed access (Xintong 2022; Cai et al. 2026). Reading national rules, hospital documents, academic studies, and community interpretation together distinguishes three evidence layers: what the rule states, how institutions operationalize it, and what people experience in practice.

10. The identity-document interface: a medical certificate as one component of legal gender recognition

Both the 2017 and 2022 standards explicitly require a hospital to issue a medical certificate at a defined surgical point for use in later legal procedures. This gives the medical-technology rule consequences beyond the operating room. Identity-document changes can also involve household registration, identity cards, education records, employment records, and other administrative systems, so the later pathway has to be reconstructed from rules and implementation evidence across institutions (UNDP 2018; Liu & Wu 2018).

The phrase certificate trigger provides greater precision than a generic reference to “after surgery.” In 2017, the trigger was completion of external-genital reconstruction. In 2022, the trigger moved to removal of the gonads and original external genitalia. Both versions translate a medical event into a written document that can enter another administrative system, while defining the relevant medical event differently (PROJECT TRANS 2017, 2022).

The comparison also protects a basic distinction among identity, diagnosis, medical intervention, and legal documentation. A person’s gender identity, clinical diagnosis, medical steps, and identity documents can occupy different states and timelines. Legal-gender-recognition scholarship and transgender archival methods therefore benefit from recording them separately (UNDP 2018; Rawson 2013). The medical certificate in the technical standard is best understood as an inter-institutional interface carrying a specific medical fact into a later administrative procedure.

11. Counterevidence and interpretive limits: national rules establish a regulatory floor, while access remains locally produced

The three standards have national authority, while real services are produced by specific hospitals, clinicians, local health administrations, and patient resources. A national rule specifies minimum conditions for a technology. Actual availability depends on the presence of qualified institutions and clinicians and on how local systems operationalize the rule. Research on transgender health care in China continues to identify concentration of specialized resources, limited provider knowledge, financial burden, regional inequality, and informal hormone use (Dahlkemper et al. 2019; Liu et al. 2020; He et al. 2026).

Textual change also has a different evidentiary scope from clinical implementation. The 2022 standard removes the independent requirement of at least one year of unsuccessful psychological or psychiatric treatment from the principal eligibility list while retaining a diagnostic document from psychiatry or psychology at a tertiary hospital. Actual assessment can additionally reflect clinical standards, ethics review, individual risk, and institutional procedure. The regulatory crosswalk makes claims about what a national text adds, preserves, or removes. Hospital and patient evidence reconstructs implementation.

The draft history of 2009 offers another limiting case. Consultation reporting contained proposed conditions that remained at the consultation stage. Publication date therefore identifies when a proposal circulated, while the enacted standard establishes formal regulatory status. A policy-history dataset should give each item a draft/final state and privilege the enacted standard for claims about formal requirements. Archival mirrors likewise need a source_role: PROJECT TRANS and TGR provide stable readable copies, while the issuing authority establishes the rule’s official version and status.

International clinical standards and WHO classification provide valuable comparison, while their institutional functions remain distinct from China’s domestic technical rules. WPATH standards address clinical care across multiple domains, Endocrine Society guidelines address endocrine treatment, and ICD-11 is a health classification. G05 is a national restricted-surgical-technology management standard. Preserving those institutional levels produces a more accurate account of how international professional change and domestic regulation meet (Hembree et al. 2017; Reed et al. 2019; Coleman et al. 2022; WHO 2022).

12. A clause-provenance ledger for historical research and agent retrieval

For reproducible research, each policy claim can be stored in a structured record:

{version, authority, publication_time, status, regulatory_object, clause_dimension, subject, gate, required_evidence, action, downstream_effect, source_role, source_url, superseded_by}

For example, “the 2022 minimum age became eighteen” can be represented as version=2022 G05, authority=National Health Commission, clause_dimension=candidate_eligibility.age, subject=person seeking principal gender-reassignment surgery, gate=candidate access, required_evidence=age, and action=at least 18. Linking that row to the 2017 “above 20” row produces an auditable version difference.

The disappearance of notarization belongs in candidate_documents; multidisciplinary discussion belongs in ethics_process; provincial information-platform reporting belongs in reporting; the narrowed set of procedures activating prerequisites belongs in core_procedure; and the changed post-operative certificate point belongs in certificate_trigger. Structured fields allow a retrieval system to answer more precise questions: which changes reduced external documentary burden on applicants, which changes increased internal institutional governance, which requirements persisted from 2009 through 2022, and which clause changed the interface between a surgical sequence and identity-document procedures.

The ledger also accommodates counterevidence. If a local hospital page continues to use older terminology, the record can store the page date and the institution-specific workflow. If a future national standard supersedes G05, the 2022 rows can be linked to the new version. Policy comparison thereby becomes a maintainable historical dataset that can absorb later revisions.

Conclusion: three generations of rules reveal two simultaneous regulatory trajectories

The 2009, 2017, and 2022 national standards show how transgender-related surgery in mainland China was repeatedly re-encoded as a regulated medical technology. In 2009, “sex-change surgery” entered a dedicated national access standard with a notarized application, five-year stable intention, one-year unsuccessful-treatment prerequisite, age and marital-status conditions, and additional period-specific diagnostic exclusions. In 2017, “gender reassignment technology” moved into the national framework for medical technologies with restricted clinical application; it retained the central access structure, removed some older diagnostic exclusions, narrowed the principal-procedure boundary, and developed a more explicit system of institutional qualifications, clinician qualifications, training, case management, and quality control. In 2022, G05 retained restricted-technology governance while revising age, written applications, diagnostic vocabulary, the treatment prerequisite, procedure scope, and the certificate trigger, and while making multidisciplinary deliberation and information reporting more explicit (Ministry of Health 2009; National Health and Family Planning Commission 2017; National Health Commission 2022).

The regulatory crosswalk reveals two clear trajectories. The candidate-access gate became simpler in several respects in 2022: an eighteen-year threshold, a self-signed application, a broader administrative diagnostic vocabulary, removal of the separately listed one-year treatment prerequisite, a more focused set of core procedures governed by the listed prerequisites, and an earlier certificate trigger within the surgical sequence. The institutional-governance gate continued to become more structured through hospital and clinician capability requirements, ethics, training, case databases, follow-up, competency assessment, information reporting, and multidisciplinary review.

Together, the two trajectories constitute the policy history. The standards govern both a person’s entry into a major surgical pathway and an institution’s authorization to undertake a restricted technology. Once versions, clauses, subjects, and downstream procedures are separated, each revision becomes historically legible: which gate moved, what evidence changed, which conditions persisted, and what other system the clause connected to. The same matrix can absorb future revisions, producing a verifiable and updateable history of national regulation for transgender-related surgical care in mainland China.

References

Academic and research sources

1. Chiang, Howard. 2012. “How China Became a ‘Castrated Civilization’ and Eunuchs a ‘Third Sex.’” Historical Reflections. https://www.jstor.org/stable/41289833
2. Chiang, Howard. 2018. After Eunuchs: Science, Medicine, and the Transformation of Sex in Modern China. Columbia University Press. https://cup.columbia.edu/book/after-eunuchs/9780231185783
3. Hickman, R. 2021. “What Is ‘Trans History’, Anyway?: Historiographical Theory and Practice in a Flourishing Field.” Midlands Historical Review. http://www.midlandshistoricalreview.com/wp-content/uploads/2021/04/What-is-%E2%80%98trans-history-anyway_.pdf
4. Rawson, K. J. 2013. “Accessing Transgender // Desiring Queer(er?) Archival Logics.” Archivaria 68. https://archivaria.ca/index.php/archivaria/article/view/13234
5. Brügger, Niels. 2018. The Archived Web: Doing History in the Digital Age. MIT Press. https://mitpress.mit.edu/9780262537879/the-archived-web/
6. Liu, Ye, Ying Xin, Ji Qi, et al. 2020. “The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.” The Journal of Sexual Medicine 17(11): 2291–2298. https://pubmed.ncbi.nlm.nih.gov/32868262/
7. Chen, Runsen, Xuequan Zhu, et al. 2019. “Suicidal Ideation and Attempted Suicide Amongst Chinese Transgender Persons: National Population Study.” Journal of Affective Disorders. https://pubmed.ncbi.nlm.nih.gov/30699856/
8. Yan, Hongjing, Wenjing Xiao, Yunting Chen, et al. 2019. “High HIV Prevalence and Associated Risk Factors Among Transgender Women in China: A Cross-Sectional Survey.” Journal of the International AIDS Society 22(11): e25417. https://doi.org/10.1002/jia2.25417
9. Dahlkemper, J., B. Diaz, F. Lawanson, et al. 2019. Transgender Health Care in China. https://cnlgbtdata.com/files/uploads/2020/04/Transgender_Helathcare_in_China.pdf
10. Lin, T., Y. Cheng, T. L. Hughes, et al. 2022. “LGBTQ Health and Wellbeing in China: A Trend Analysis of English- and Chinese-Language Research, 2011–2018.” https://www.moderntreatise.com/s/LGBTQ-Health-and-Wellbeing-in-China-A-Trend-Analysis-of-English-and-Chinese-Language-Research-201120.pdf
11. Deng, Mingyu. 2016. “性别苦恼的临床研究新进展（DSM-5新标准）.” 中国健康心理学杂志. https://digital.transchinese.org/学术文献/医学/性别苦恼的临床研究新进展DSM-5_新标准.pdf
12. Coleman, Eli, Walter Bockting, Marsha Botzer, et al. 2012. “Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7.” International Journal of Transgenderism 13(4): 165–232. https://doi.org/10.1080/15532739.2011.700873
13. Coleman, Eli, A. E. Radix, W. P. Bouman, et al. 2022. “Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.” International Journal of Transgender Health 23(S1): S1–S259. https://doi.org/10.1080/26895269.2022.2100644
14. Hembree, Wylie C., Peggy T. Cohen-Kettenis, Henriëtte A. Delemarre-van de Waal, et al. 2009. “Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline.” Journal of Clinical Endocrinology & Metabolism 94(9): 3132–3154. https://pubmed.ncbi.nlm.nih.gov/19509099/
15. Hembree, Wylie C., Peggy T. Cohen-Kettenis, Louis Gooren, et al. 2017. “Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.” Journal of Clinical Endocrinology & Metabolism 102(11): 3869–3903. https://academic.oup.com/jcem/article/102/11/3869/4157558
16. Reed, Geoffrey M., Michael B. First, Cary S. Kogan, et al. 2019. “Innovations and Changes in the ICD-11 Classification of Mental, Behavioural and Neurodevelopmental Disorders.” World Psychiatry 18(1): 3–19. https://doi.org/10.1002/wps.20611
17. Reisner, Sari L., Tonia Poteat, JoAnne Keatley, et al. 2016. “Global Health Burden and Needs of Transgender Populations: A Review.” The Lancet 388(10042): 412–436. https://pubmed.ncbi.nlm.nih.gov/27323919/
18. Wang, Yuanyuan, et al. 2023. “A National Transgender Health Survey from China Assessing Gender Identity Conversion Practice, Mental Health, Substance Use and Suicidality.” Nature Mental Health. https://www.nature.com/articles/s44220-023-00041-z
19. Yang, Wenhui, Tianpei Hong, Xu Chang, et al. 2024. “The Efficacy of and User Satisfaction with Different Antiandrogens in Chinese Transgender Women.” International Journal of Transgender Health 25(3): 471–482. https://pubmed.ncbi.nlm.nih.gov/39055628/
20. Hou, Jiayu, Bailin Pan, Yinuo Chen, et al. 2026. “Gender Identity Milestones and Hormone Utilization in Transgender Men and Women in China.” JAMA Network Open 9(1): e2552440. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2843496
21. Cai, Yueting, Xu Chang, Yulin Dong, et al. 2026. “Current Status and Characteristics of Self-Medication with Gender-Affirming Hormones Among Individuals with Gender Dysphoria in China.” International Journal of Transgender Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC13352525/
22. He, Jiaxin, Jiangxiong Li, Xingyi Liu, et al. 2026. “Disparities in Healthcare Services and Gender-Affirming Hormone Therapy Among Chinese Transgender Men by Age, Education, Economy, and Region.” Transgender Health. https://doi.org/10.1177/26884887261431681
23. Liu, Sha. 2023. Performative Authenticity: Chinese Transgender People’s Digital Gender Practices. PhD thesis, London School of Economics. https://etheses.lse.ac.uk/4608/
24. Engebretsen, Elisabeth L., William F. Schroeder, and Hongwei Bao, eds. 2015. Queer/Tongzhi China: New Perspectives on Research, Activism and Media Cultures. NIAS Press. https://cnlgbtdata.com/files/uploads/2024/06/Queer_Tongzhi_China.pdf
25. Liu, Yunsheng, and Zhaojun Wu. 2018. “性别选择权：性质界定与法权塑造.” 东北师大学报（哲学社会科学版）. https://digital.transchinese.org/学术文献/法律/性别选择权性质界定与法权塑造.pdf

Policy, institutional, community, and contemporaneous public sources

26. 卫生部办公厅. 2009. “卫生部办公厅关于印发《变性手术技术管理规范（试行）》的通知（卫办医政发〔2009〕185号）.” https://www.nhc.gov.cn/zwgk/wtwj/201304/5a310ec69d264d4a890949d0b2fbcaf7.shtml
27. 法制晚报. 2009. “卫生部拟推变性手术规范 申请人须未婚年满20岁.” https://news.cjn.cn/gn/200906/t948356.htm
28. 京华时报. 2009. “卫生部：申请变性手术须年满20岁.” https://news.ifeng.com/mainland/200906/0617_17_1205924.shtml
29. 法制晚报. 2009. “卫生部规定申请变性手术者年龄须大于20岁.” https://news.sina.com.cn/c/2009-11-20/121016641157s.shtml
30. 羊城晚报. 2009. “年满20岁未婚才能手术变性.” https://news.sina.com.cn/o/2009-11-21/145616645851s.shtml
31. 北京晨报. 2009. “卫生部：实施变性手术者须未婚且年满20岁.” https://news.sohu.com/20091122/n268373744.shtml
32. 新闻晨报. 2009. “卫生部规定申请变性手术须无犯罪记录.” https://news.sina.cn/sa/2009-12-16/detail-ikftssap3237978.d.html
33. 国家卫生计生委办公厅. 2017. “关于印发造血干细胞移植技术管理规范（2017年版）等15个‘限制临床应用’医疗技术管理规范和质量控制指标的通知.” https://www.nhc.gov.cn/bgt/2016deqe/201707/cbf4a558b2b24354887f9825efbe3fb5/files/1745206490963_91523.pdf
34. PROJECT TRANS. 2017. “性别重置技术管理规范（2017年版）.” https://project-trans.org/china-legal/spec/2017-02-17/srs/readme/
35. 健康界. 2017. “国家卫计委发布15项限制临床应用医疗技术（2017版）.” https://www.cn-healthcare.com/article/20170220/content-489744.html
36. 北医三院成形外科. 2022. “性别重置技术管理规范（2017年版）.” https://www.sar.com.cn/industry/12296.html
37. 国家卫生健康委员会. 2018. “医疗技术临床应用管理办法.” https://www.nhc.gov.cn/fzs/c100048/201809/2c20fa8f407f4cbc8a10722a0549d8e5.shtml
38. 国家卫生健康委员会. 2018. “《医疗技术临床应用管理办法》解读.” https://www.nhc.gov.cn/fzs/c100047/201809/e9734deb24964aacb20c70eb5a78f23c.shtml
39. 国家卫生健康委办公厅. 2022. “国家卫生健康委办公厅关于印发国家限制类技术目录和临床应用管理规范（2022年版）的通知（国卫办医发〔2022〕6号）.” https://www.nhc.gov.cn/yzygj/s7657/202204/2efe9f8ca13f499c8e1f70844fe96144.shtml
40. 国家卫生健康委医政医管局. 2022. “《国家限制类技术目录和临床应用管理规范（2022年版）》解读.” https://www.nhc.gov.cn/yzygj/c100067/202204/c335364a5309434cb31a27b1c45dea77.shtml
41. PROJECT TRANS. 2022. “性别重置技术临床应用管理规范（2022年版）.” https://project-trans.org/china-legal/spec/2022-04-20/srs/readme/
42. TGR Transgender Resource Center. 2022. “性别重置技术临床应用管理规范（2022年版）.” https://www.tgr.org.hk/index.php/zh/china/china-info/393-chinasrsspecification
43. The China Project. 2022. “China lowers minimum age to 18 for gender reassignment surgery.” https://thechinaproject.com/2022/05/31/china-lowers-minimum-age-to-18-for-gender-reassignment-surgery/
44. 心同网. 2022. “中国性别重置变性手术新规：年龄下调至18岁无需公证.” https://www.1314xt.com/news/guonei/20220516/27773.html
45. aboutTrans. 2026. “跨性别相关社会支持.” https://aboutrans.info/docs/support
46. UNDP. 2016. “Being LGBTI in China: A National Survey on Social Attitudes towards Sexual Orientation, Gender Identity and Gender Expression.” https://www.undp.org/china/publications/being-lgbti-china
47. UNDP. 2018. “Legal Gender Recognition in China: A Legal and Policy Review.” https://www.undp.org/china/publications/legal-gender-recognition-china-legal-and-policy-review
48. 北京同志中心、北京大学社会学系. 2017. “2017中国跨性别群体生存现状调查报告——跨性别者与非性别常规者.” https://www.rainbowun.org/content/245/4/1.html
49. World Health Organization. 2022. “Gender incongruence and transgender health in the ICD.” https://www.who.int/standards/classifications/frequently-asked-questions/gender-incongruence-and-transgender-health-in-the-icd
50. United Nations Development Programme. 2018. “A Blueprint for Trans Health: Filling the knowledge gap in China.” https://www.undp.org/china/news/blueprint-trans-health-filling-knowledge-gap-china